Columnist Caroline Gainer looks into evidence suggesting that her premature birth may have been a factor in her development ...

The FDA has approved Nucala (mepolizumab) as an add-on maintenance treatment for certain COPD patients whose disease isn't ...

Although there is no cure for COPD yet, there are several approved treatments that can help manage the disease and ease symptoms. Learn more about some of the specific therapies used to treat this ...

Chronic obstructive pulmonary disease (COPD) is an inflammatory disorder that causes several symptoms which make breathing difficult. These include persistent cough with mucus, wheezing, and shortness ...

DirectRx, a specialty pharmacy for people with chronic health disorders, is now part of the exclusive U.S. pharmacy network distributing Ohtuvayre (ensifentrine), a newly approved therapy for chronic ...

While the name of this column is “Life Tethered to a Concentrator,” so far, I haven’t yet discussed my journey with long-term supplemental oxygen. Today, I’d like to take you along on that journey.

Note: This is the first part of a three-part series written in collaboration with respiratory therapist Mark W. Mangus Sr., RRT, RPFT, FAARC, and oxygen expert Ryan Diesem. One of the more hotly ...

It’s not uncommon for those of us with chronic obstructive pulmonary disease (COPD) to suffer from cachexia, or wasting disease. A 2019 study found that people with cachexia or pre-cachexia had a ...

Apogee Therapeutics has begun dosing healthy volunteers in a Phase 1 clinical trial of APG808, the company’s anti-inflammatory injection therapy for chronic obstructive pulmonary disease (COPD), ...